N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 14.8 CNY -0.13%
Market Cap: 23.9B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

Net Margin
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

-10.9%
Current
20%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.9%
=
Net Income
-408.9m
/
Revenue
3.8B

Net Margin Across Competitors

Country CN
Market Cap 23.9B CNY
Net Margin
-11%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 746.8B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 365.6B USD
Net Margin
17%
Country US
Market Cap 249.1B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.9%
=
Net Income
-408.9m
/
Revenue
3.8B
What is the Net Margin of Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

Based on Nanjing King-friend Biochemical Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -10.9%.